<i>In vitro</i> pharmacokinetic/pharmacodynamic modeling of the effect of mucin on polymyxin B activity against <i>Acinetobacter baumannii</i>
Mathilde Lacroix(Roche (Switzerland)), Alexia Chauzy(Inserm), Hamasseh Shirvani(Roche (Switzerland)), Claudia Zampaloni(Roche (Switzerland)), Caterina Bissantz(Roche (Switzerland)), Sandrine Marchand(Inserm), William Couet(Inserm), Jérémy Moreau(Inserm), Hélène Mirfendereski(Centre Hospitalier Universitaire de Poitiers)
Cited by 3
Related Papers
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
|Intensive Care Medicine|2017|149
A Real-World Perspective on Molecular Design
|Journal of Medicinal Chemistry|2016|120